Enzychem Lifesciences Corp.(KR:183490)
â‚©990.000.00 (0.00%)
KR:183490
Enzychem Lifesciences Corp. financials statements
â‚©990.00
At close:0.00 (0.00%)
Want to see KR:183490 full AI Analyst Report?
Enzychem Lifesciences Corp. (183490) Ratios
Enzychem Lifesciences Corp. Ratios
KR:183490's free cash flow for Q4 2025 was ₩-8.53B. For the 2025 fiscal year, KR:183490's free cash flow was decreased by ₩-4.82M and operating cash flow was ₩-8.53B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 14.06 | 13.03 | 12.33 | 5.21 | 2.05 |
| Quick Ratio | 12.62 | 11.97 | 11.27 | 4.98 | 1.89 |
| Cash Ratio | 0.95 | 0.91 | 1.09 | 0.18 | 0.05 |
| Solvency Ratio | -1.53 | -0.92 | -0.34 | -0.50 | -0.44 |
| Operating Cash Flow Ratio | -1.34 | -0.05 | -0.72 | -0.34 | -0.35 |
| Short-Term Operating Cash Flow Coverage | -3.40 | -0.15 | -3.02 | -0.40 | -0.38 |
| Net Current Asset Value | â‚© 105.95B | â‚© 127.97B | â‚© 157.56B | â‚© 174.50B | â‚© 51.36B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.03 | 0.15 | 0.39 |
| Debt-to-Equity Ratio | 0.04 | 0.03 | 0.03 | 0.19 | 0.70 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.03 | 0.16 | 0.41 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.04 |
| Financial Leverage Ratio | 1.08 | 1.13 | 1.09 | 1.23 | 1.78 |
| Debt Service Coverage Ratio | -4.29 | -4.51 | -1.31 | -0.27 | -0.28 |
| Interest Coverage Ratio | -64.96 | -55.27 | -23.15 | -1.46 | -2.18 |
| Debt to Market Cap | 0.03 | 0.03 | 0.03 | 0.34 | 0.11 |
| Interest Debt Per Share | 65.07 | 64.95 | 74.03 | 724.85 | 1232.31 |
| Net Debt to EBITDA | 0.20 | 0.29 | 1.71 | -2.29 | -2.75 |
| Profitability Margins | |||||
| Gross Profit Margin | 4.99% | 5.57% | 5.72% | 9.07% | 1.25% |
| EBIT Margin | -26.62% | -28.23% | -12.18% | -58.38% | -87.03% |
| EBITDA Margin | -22.00% | -23.76% | -7.56% | -49.41% | -77.84% |
| Operating Profit Margin | -19.32% | -17.05% | -18.88% | -55.04% | -90.33% |
| Pretax Profit Margin | -26.92% | -28.54% | -12.99% | -96.03% | -128.42% |
| Net Profit Margin | -26.76% | -28.57% | -12.27% | -94.20% | -121.28% |
| Continuous Operations Profit Margin | -26.70% | -28.55% | -12.37% | -94.20% | -121.28% |
| Net Income Per EBT | 99.41% | 100.10% | 94.41% | 98.09% | 94.44% |
| EBT Per EBIT | 139.37% | 167.38% | 68.81% | 174.48% | 142.17% |
| Return on Assets (ROA) | -12.20% | -12.16% | -4.41% | -10.14% | -20.94% |
| Return on Equity (ROE) | -13.18% | -13.79% | -4.82% | -12.44% | -37.32% |
| Return on Capital Employed (ROCE) | -9.32% | -7.74% | -7.27% | -7.14% | -26.12% |
| Return on Invested Capital (ROIC) | -9.01% | -7.54% | -6.78% | -5.95% | -15.30% |
| Return on Tangible Assets | -12.53% | -12.52% | -4.53% | -10.23% | -22.01% |
| Earnings Yield | -13.99% | -16.77% | -5.76% | -22.99% | -6.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.22 | 4.39 | 3.76 | 2.58 | 3.43 |
| Payables Turnover | 47.76 | 29.06 | 11.04 | 16.19 | 10.08 |
| Inventory Turnover | 5.42 | 6.03 | 4.80 | 2.47 | 2.72 |
| Fixed Asset Turnover | 3.54 | 3.20 | 2.91 | 1.14 | 1.49 |
| Asset Turnover | 0.46 | 0.43 | 0.36 | 0.11 | 0.17 |
| Working Capital Turnover Ratio | 0.55 | 0.52 | 0.45 | 0.23 | 0.30 |
| Cash Conversion Cycle | 110.28 | 131.18 | 140.03 | 266.35 | 204.76 |
| Days of Sales Outstanding | 50.56 | 83.22 | 97.00 | 141.31 | 106.55 |
| Days of Inventory Outstanding | 67.36 | 60.51 | 76.09 | 147.59 | 134.41 |
| Days of Payables Outstanding | 7.64 | 12.56 | 33.06 | 22.54 | 36.20 |
| Operating Cycle | 117.92 | 143.74 | 173.09 | 288.90 | 240.96 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -142.17 | -7.28 | -120.99 | -217.11 | -372.56 |
| Free Cash Flow Per Share | -152.23 | -13.49 | -148.14 | -338.59 | -490.46 |
| Dividend Paid and CapEx Coverage Ratio | -14.13 | -1.17 | -4.46 | -1.79 | -3.16 |
| Capital Expenditure Coverage Ratio | -14.13 | -1.17 | -4.46 | -1.79 | -3.16 |
| Operating Cash Flow Coverage Ratio | -2.28 | -0.12 | -1.81 | -0.38 | -0.36 |
| Operating Cash Flow to Sales Ratio | -0.16 | -0.01 | -0.13 | -0.54 | -0.81 |
| Free Cash Flow Yield | -9.10% | -0.81% | -7.76% | -20.46% | -5.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.15 | -5.96 | -17.36 | -4.35 | -16.38 |
| Price-to-Sales (P/S) Ratio | 1.91 | 1.70 | 2.13 | 4.10 | 19.87 |
| Price-to-Book (P/B) Ratio | 0.94 | 0.82 | 0.84 | 0.54 | 6.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.99 | -124.02 | -12.89 | -4.89 | -18.66 |
| Price-to-Operating Cash Flow Ratio | -11.77 | -229.74 | -15.79 | -7.62 | -24.56 |
| Price-to-Earnings Growth (PEG) Ratio | 0.43 | -0.04 | 0.24 | 0.14 | -0.17 |
| Enterprise Value Multiple | -8.49 | -6.88 | -26.47 | -10.58 | -28.28 |
| Enterprise Value | 126.59B | 126.43B | 152.13B | 139.26B | 505.73B |
| EV to EBITDA | -8.49 | -6.88 | -26.47 | -10.58 | -28.28 |
| EV to Sales | 1.87 | 1.63 | 2.00 | 5.23 | 22.01 |
| EV to Free Cash Flow | -10.74 | -118.92 | -12.11 | -6.24 | -20.67 |
| EV to Operating Cash Flow | -11.50 | -220.29 | -14.83 | -9.72 | -27.21 |
| Tangible Book Value Per Share | 1741.42 | 1982.94 | 2226.51 | 3025.55 | 1366.73 |
| Shareholders’ Equity Per Share | 1775.62 | 2034.63 | 2282.42 | 3058.69 | 1496.39 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | -0.00 | 0.05 | 0.02 | 0.06 |
| Revenue Per Share | 874.66 | 981.80 | 896.84 | 403.86 | 460.48 |
| Net Income Per Share | -234.08 | -280.50 | -110.00 | -380.44 | -558.47 |
| Tax Burden | 0.99 | 1.00 | 0.94 | 0.98 | 0.94 |
| Interest Burden | 1.01 | 1.01 | 1.07 | 1.65 | 1.48 |
| Research & Development to Revenue | 0.05 | 0.06 | 0.07 | 0.25 | 0.41 |
| SG&A to Revenue | 0.08 | 0.08 | 0.08 | 0.17 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | -0.01 | 0.03 |
| Income Quality | 0.61 | 0.03 | 1.09 | 0.57 | 0.67 |
Currency in KRW

